1-8 of 8
Peter G. Linde
Close
Sort by
Journal Articles

Evaluating Luspatercept Responders in the Phase 3, Randomized, Double-Blind, Placebo-Controlled BELIEVE Trial of Luspatercept in Adult Beta-Thalassemia Patients (Pts) Who Require Regular Red Blood Cell (RBC) Transfusions

Vip Viprakasit, Ali Taher, Olivier Hermine, John Porter, Antonio Piga, Kevin H. M. Kuo, MDMSc,FRCPC, Thomas Coates, MD, Ersi Voskaridou, Hong Keng Liew, Silverio Perrotta, Abderrahim Khelif, Antonis Kattamis, Abderrahmane Laadem, Jeevan K. Shetty, Wen-Ling Kuo, Dimana Miteva, Tatiana Zinger, Daniel Sinsimer, Peter G. Linde, Maria Domenica Cappellini, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3545.
https://doi.org/10.1182/blood-2019-122685
Published: 2019
Journal Articles

Luspatercept Significantly Reduces Red Blood Cell (RBC) Transfusion Burden, Regardless of Gene Mutation Frequency, Spectrum, and Prognostic Significance, Among Patients (Pts) with LR-MDS Enrolled in the MEDALIST Trial

Uwe Platzbecker, Diana Dunshee, Rami S. Komrokji, MD, Ghulam J. Mufti, Guillermo Garcia-Manero, MD, Rena Buckstein, MD FRCPC, Valeria Santini, MD, María Díez-Campelo, MD PhD, Mikkael A. Sekeres, MD MS, Wendy L. See, Kevin Tsai, Alberto Risueño, Jianglin Ma, Martin Schwickart, Anita Rampersad, Jennie Zhang, Abderrahmane Laadem, Daniel Menezes, Kyle MacBeth, PhD, Peter G. Linde, Joseph G. Reynolds, PhD, Alan F. List, MD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2999.
https://doi.org/10.1182/blood-2019-123655
Published: 2019
Journal Articles

A Phase 2 Study of Luspatercept in Patients with Myelofibrosis-Associated Anemia

Aaron T. Gerds, MD MS, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Marina Kremyanskaya, Jason R. Gotlib, Jeanne M. Palmer, Kelly McCaul, Vincent Ribrag, Adam J. Mead, MD PhD, Claire N Harrison, Professor, Ruben A Mesa, MD, Jean-Jacques Kiladjian, MD PhD, Giovanni Barosi, Robert Peter Gale, MD PhD DSc, Abderrahmane Laadem, Joseph Pariseau, PharmD, Torsten Gerike, MD, Jennie Zhang, Peter G. Linde, Joseph G. Reynolds, PhD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 557.
https://doi.org/10.1182/blood-2019-122546
Published: 2019
Journal Articles

Assessment of Longer-Term Efficacy and Safety in the Phase 3, Randomized, Double-Blind, Placebo-Controlled MEDALIST Trial of Luspatercept to Treat Anemia in Patients (Pts) with Revised International Prognostic Scoring System (IPSS-R) Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Pierre Fenaux, MD PhD, Ghulam J. Mufti, Rena Buckstein, MD FRCPC, Valeria Santini, MD, María Díez-Campelo, MD PhD, Carlo Finelli, Mario Cazzola, MD, Osman Ilhan, MD, Mikkael A. Sekeres, MD MS, Rami S. Komrokji, MD, Alan F. List, MD, Amer M. Zeidan, MBBS, MHS, Amit Verma, MBBS, Abderrahmane Laadem, Rodrigo Ito, Jennie Zhang, Anita Rampersad, Daniel Sinsimer, Peter G. Linde, Guillermo Garcia-Manero, MD, Uwe Platzbecker, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 841.
https://doi.org/10.1182/blood-2019-123064
Published: 2019
Journal Articles

Hematologic Improvement-Neutrophil and -Platelet in the MEDALIST Trial: Multilineage Data from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Guillermo Garcia-Manero, MD, Ghulam J. Mufti, Pierre Fenaux, MD PhD, Rena Buckstein, MD FRCPC, Valeria Santini, MD, María Díez-Campelo, MD PhD, Carlo Finelli, Mario Cazzola, MD, Osman Ilhan, Mikkael A. Sekeres, MD MS, Alan F. List, MD, Abderrahmane Laadem, Rodrigo Ito, Jennie Zhang, Anita Rampersad, Daniel Sinsimer, Peter G. Linde, Uwe Platzbecker, MD, Rami Komrokji
Journal: Blood
Blood (2019) 134 (Supplement_1): 4243.
https://doi.org/10.1182/blood-2019-123048
Published: 2019
Journal Articles

Effects of Luspatercept on Iron Overload and Impact on Responders to Luspatercept: Results from the BELIEVE Trial

John Porter, Maria Domenica Cappellini, MD, Thomas Coates, MD, Olivier Hermine, Vip Viprakasit, MD DPhil, Ersi Voskaridou, Hong Keng Liew, Silverio Perrotta, Abderrahim Khelif, Antonis Kattamis, Abderrahmane Laadem, Jeevan K. Shetty, Wen-Ling Kuo, Dimana Miteva, Tatiana Zinger, Peter G. Linde, Daniel Sinsimer, Ali Taher
Journal: Blood
Blood (2019) 134 (Supplement_1): 2245.
https://doi.org/10.1182/blood-2019-122561
Published: 2019
Journal Articles

The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Pierre Fenaux, MD PhD, Uwe Platzbecker, Ghulam J. Mufti, Guillermo Garcia-Manero, MD, Rena Buckstein, MD FRCPC, Valeria Santini, María Díez-Campelo, Carlo Finelli, MD, Mario Cazzola, Osman Ilhan, MD, Mikkael A. Sekeres, MD MS, José F. Falantes, Beatriz Arrizabalaga, MD PhD, Flavia Salvi, Valentina Giai, Paresh Vyas, David Bowen, MD PhD, Dominik Selleslag, MD, Amy E. DeZern, MD, Joseph G. Jurcic, MD, Ulrich Germing, MD, Katharina S. Götze, MD, Bruno Quesnel, Odile Beyne-Rauzy, Thomas Cluzeau, MD PhD, Maria Teresa Voso, Dominiek Mazure, Edo Vellenga, Peter L Greenberg, MD, Eva Hellström-Lindberg, MD PhD, Amer M. Zeidan, MBBS, MHS, Abderrahmane Laadem, MD, Aziz Benzohra, Jennie Zhang, Anita Rampersad, Peter G. Linde, Matthew L. Sherman, Rami S. Komrokji, MD, Alan F. List, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1.
https://doi.org/10.1182/blood-2018-99-110805
Published: 2018
Journal Articles

The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions

Maria Domenica Cappellini, MD, Vip Viprakasit, MD DPhil, Ali Taher, MDPhD, Pencho Georgiev, MD, Kevin H. M. Kuo, MDMSc,FRCPC, Thomas D. Coates, MD, Ersi Voskaridou, MD, Hong Keng Liew, Idit Pazgal-Kobrowski, Gianluca Forni, Silverio Perrotta, Abderrahim Khelif, Ashutosh Lal, MD, Antonis Kattamis, Efthymia Vlachaki, Raffaella Origa, MD, Yesim Aydinok, Mohamed Bejaoui, P. Joy Ho, Lee Ping Chew, Ping Chong Bee, Soo Min Lim, Meng-Yao Lu, Adisak Tantiworawit, Penka Ganeva, Liana Gercheva, Farrukh Shah, Ellis J. Neufeld, Abderrahmane Laadem, MD, Jeevan K. Shetty, Jun Zou, MDPhD, Dimana Miteva, PhD, Tatiana Zinger, PhD, Peter G. Linde, Matthew L. Sherman, Olivier Hermine, MDPhD, John Porter, MA MDFRCP FRCPath, Antonio Piga
Journal: Blood
Blood (2018) 132 (Supplement 1): 163.
https://doi.org/10.1182/blood-2018-163
Published: 2018